Aurora Cannabis

Historical price data

Aurora Cannabis is a vertically integrated cannabis company with a dual mission: to be a leading supplier in the global adult-use market and to advance the science of medical cannabis through clinical research and product standardization. The company achieved rapid scale post-Canadian legalization, constructing some of the world's largest automated cultivation facilities and establishing a significant international medical export footprint. Its current strategy focuses on achieving positive free cash flow by rationalizing operations, optimizing its asset base, and targeting high-margin medical segments domestically and abroad, particularly in Europe and Australia.

Aurora's platform integrates large-scale, automated controlled-environment agriculture (CEA) for consistent cultivation with advanced extraction and formulation science to develop standardized, dose-controlled medical cannabis products including oils, capsules, and edibles.

Aurora competes with large Canadian LPs like Tilray and Canopy Growth in a crowded domestic recreational market, and with other EU-GMP certified producers like Tilray and Cronos in the international medical sector. Its advantages are scale of certified production and an established global distribution network, but it faces challenges from better-capitalized rivals and margin pressure.